Companies
Company Logo
Oneliner
Company Logo
Oneliner
Add Entity
snc-logo

Startup Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Watchlists
My Saved Searches
Following
Inbox
About Us
Glossary

snackbar-icon
title

Create new Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
Notifications Off
Public content (accessible by all Finder users)

Add to watchlist

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Already have an account? Login

    Verify your email

    We’ve sent a verification link to [email protected]
    Reset password
    Don't have an account? Sign up

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    Home > Multinationals > Adicet Bio
    Claimed by owner Last Update 22.2.2023 Suggest Edits Claim Profile
    Claimed by owner
    Adicet Bio

    Adicet Bio

    Former names: resTORbio

    Pharmaceuticals • United States

    Hidden Profile undefined terms of use
    Public on NASDAQSep, 2020
    Adicet Bio
    About
    Exits
    Extensions
    Israeli Portfolio
    News
    Gallery
    Dec 6, 2021
    www.globenewswire.com
    Adicet Bio Announces Positive Interim Clinical Data From First-Ever Allogeneic, Off-The-Shelf, Gamma Delta CAR T Investigational Cell Therapy
    Sep 15, 2020
    www.globenewswire.com
    Adicet Announces Completion of Merger with resTORbio
    #Acquisition #Public Trading #Management Changes
    Apr 29, 2020
    www.globenewswire.com
    resTORbio and Adicet Bio Announce Merger Agreement to Advance Allogeneic Gamma Delta CAR-T Cell Therapy Technology
    #Acquired-by, Investment
    Oct 3, 2019
    en.globes.co.il
    aMoon invests in $80m Adicet Bio financing round
    #Investment
    Oct 2, 2019
    www.calcalistech.com
    Allogenic Immunotherapy Company Adicet Bio Raises $80 Million
    #Investment
    Jan 27, 2016
    en.globes.co.il
    Adicet buys Applied Immune Technologies
    #Acquisition #Investment

    About

    Adicet Bio Inc is a preclinical-stage biotechnology company engaged in the design and development of immunotherapies for cancer and other disease indications, with a focus on novel universal immune cell therapies. The company's development is based on gamma delta T cells engineered with chimeric antigen receptors or T-cell receptors.

    In 2016, Adicet Bio Inc acquired Israeli company Applied Immune Technologies (AIT), which develops immunotherapies. AIT, today called Adicet Bio Israel, continues its operations in Israel as Adicet's wholly owned subsidiary.

    Founded

    In Israel Since

    Employees Worldwide

    Employees

    Market Cap

    Market Cap Update

    11/2023

    Country

    United States

    News

      (6)
    Dec 6, 2021
    www.globenewswire.com
    Adicet Bio Announces Positive Interim Clinical Data From First-Ever Allogeneic, Off-The-Shelf, Gamma Delta CAR T Investigational Cell Therapy
    Sep 15, 2020
    www.globenewswire.com
    Adicet Announces Completion of Merger with resTORbio
    #Acquisition #Public Trading #Management Changes
    Apr 29, 2020
    www.globenewswire.com
    resTORbio and Adicet Bio Announce Merger Agreement to Advance Allogeneic Gamma Delta CAR-T Cell Therapy Technology
    #Acquired-by, Investment
    Oct 3, 2019
    en.globes.co.il
    aMoon invests in $80m Adicet Bio financing round
    #Investment
    Oct 2, 2019
    www.calcalistech.com
    Allogenic Immunotherapy Company Adicet Bio Raises $80 Million
    #Investment
    Jan 27, 2016
    en.globes.co.il
    Adicet buys Applied Immune Technologies
    #Acquisition #Investment

    The Team

    (2)
    CS
    Chen Schor
    President & CEO
    RE
    Reut Erel-Segal
    Scientific research team leader

    Connect with

    What is the reason for connecting? *
    Your company *

    Your organization type *

    Please enter a valid organization type
    Your position *
    Add invitation message
    0/300

    Sending invitation...

    Exits

    Public Offering
    Undisclosed
    Sep 2020
    Stock Exchange
    NASDAQ logo
    NASDAQ
    Valuation Undisclosed
    Undisclosed

    Extensions

    Events

    Israeli Acquisitions

    ( 1 )
    Company Name Description Founded Business Model Employees Funding Stage Raised
    Applied Immune Technologies logo
    Applied Immune Technologies
    TCRL Antibodies for Therapeutic Applications 2006 B2B 1-10 Acquired $4.4M

    Locations

    Israel

    Sderot Chicago 1, Haifa, Israel

    Offices Abroad

    Menlo Park, CA, USA

    Locations

    Israel

    Sderot Chicago 1, Haifa, Israel

    Offices Abroad

    Menlo Park, CA, USA

    Notes

    Content Writer
    undefined
    BI Verification
    undefined
    Phone Number
    undefined
    Israel Register ID
    undefined
    Confidence Score
    undefined
    Missing Fields
    undefined
    Profile Creator
    undefined
    Profile Update
    undefined
    undefined

    Add Article

    0/500